COVID-19: Melatonin as a potential adjuvant treatment

Volume: 250, Pages: 117583 - 117583
Published: Jun 1, 2020
Abstract
This article summarizes the likely benefits of melatonin in the attenuation of COVID-19 based on its putative pathogenesis. The recent outbreak of COVID-19 has become a pandemic with tens of thousands of infected patients. Based on clinical features, pathology, the pathogenesis of acute respiratory disorder induced by either highly homogenous coronaviruses or other pathogens, the evidence suggests that excessive inflammation, oxidation, and an...
Paper Details
Title
COVID-19: Melatonin as a potential adjuvant treatment
Published Date
Jun 1, 2020
Volume
250
Pages
117583 - 117583
Citation AnalysisPro
  • Scinapse’s Top 10 Citation Journals & Affiliations graph reveals the quality and authenticity of citations received by a paper.
  • Discover whether citations have been inflated due to self-citations, or if citations include institutional bias.